FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)

FSD Pharma is committed to our pursuit of developing innovative novel biotechnologies to bring advanced neurodegenerative and mental health treatments to market. Through our rigorous drug development pipeline, we are closer to achieving our mission of obtaining Total Brain Health for all. FSD Pharma is rapidly advancing our compounds through preclinical and clinical development to help treat individuals affected by Multiple Sclerosis and mental health diseases. Follow along as we develop hope for a positive tomorrow.